The drugs molecular structure has been public for years, since Eli Lilly published it in a research paper in 2022
In September 2025, clinical research was published on weight loss for two oral incretin therapies: an oral version of semaglutide and Orforglipron, also a GLP-1 receptor agonist
Combined with regular movement, strength training, quality sleep and stress management, these foods can help you feel fuller, reduce cravings, support healthy blood sugar and make sustainable weight loss feel much easier
A few days after the suit was filed, the agency said it would re-evaluate its decision, allowing compounders to continue preparing tirzepatide in the meantime
The history of biomarkers in psychiatry: lessons learned, lessons forgotten, lessons rediscovered